Cargando…

Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease

This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Younes, Laurent, Albert, Marilyn, Miller, Michael I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110355/
https://www.ncbi.nlm.nih.gov/pubmed/25101236
http://dx.doi.org/10.1016/j.nicl.2014.04.009
_version_ 1782327985877024768
author Younes, Laurent
Albert, Marilyn
Miller, Michael I.
author_facet Younes, Laurent
Albert, Marilyn
Miller, Michael I.
author_sort Younes, Laurent
collection PubMed
description This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8–10 years prior to onset, followed by the hippocampus, 2–4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4% (left side) and 1.6% (right side) annually. The same changepoint model for ERC volume gives 3.0% and 2.7% on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease.
format Online
Article
Text
id pubmed-4110355
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-41103552014-08-06 Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease Younes, Laurent Albert, Marilyn Miller, Michael I. Neuroimage Clin Article This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8–10 years prior to onset, followed by the hippocampus, 2–4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4% (left side) and 1.6% (right side) annually. The same changepoint model for ERC volume gives 3.0% and 2.7% on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease. Elsevier 2014-04-21 /pmc/articles/PMC4110355/ /pubmed/25101236 http://dx.doi.org/10.1016/j.nicl.2014.04.009 Text en © 2014 The Authors. Published by Elsevier Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Younes, Laurent
Albert, Marilyn
Miller, Michael I.
Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
title Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
title_full Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
title_fullStr Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
title_full_unstemmed Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
title_short Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
title_sort inferring changepoint times of medial temporal lobe morphometric change in preclinical alzheimer's disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110355/
https://www.ncbi.nlm.nih.gov/pubmed/25101236
http://dx.doi.org/10.1016/j.nicl.2014.04.009
work_keys_str_mv AT youneslaurent inferringchangepointtimesofmedialtemporallobemorphometricchangeinpreclinicalalzheimersdisease
AT albertmarilyn inferringchangepointtimesofmedialtemporallobemorphometricchangeinpreclinicalalzheimersdisease
AT millermichaeli inferringchangepointtimesofmedialtemporallobemorphometricchangeinpreclinicalalzheimersdisease
AT inferringchangepointtimesofmedialtemporallobemorphometricchangeinpreclinicalalzheimersdisease